Cargando…

The distribution of hypertrophy in anderson fabry disease

Detalles Bibliográficos
Autores principales:	Sado, Daniel M, Banypersad, Sanjay M, Elliott, Perry M, Moon, James C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106636/ http://dx.doi.org/10.1186/1532-429X-13-S1-P278

Ejemplares similares

Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
por: Sado, Daniel, et al.
Publicado: (2013)

Myocardial strain in a health and disease: CMR feature tracking analysis in cardiac hypertrophy
por: Barison, Andrea, et al.
Publicado: (2013)

CMR demonstration of multiple morphological phenotypes in Anderson-Fabry disease
por: Deva, Djeven P, et al.
Publicado: (2015)

Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018)

Assessment of the interstitial volume in healthy volunteers. An equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Reduced native right ventricular T(1 )in Anderson-Fabry disease as compared to patients with pulmonary hypertension
por: Pagano, Joseph J, et al.
Publicado: (2014)

Relationship between MRI derived right ventricular mass and left ventricular involvement in patients with anderson-fabry disease
por: Li, Qin, et al.
Publicado: (2015)

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

Native T1 mapping versus CMR Feature Tracking (FT) derived strain analysis for the assessment of cardiac disease manifestation in Anderson Fabry
por: Reid, Anna B, et al.
Publicado: (2016)

Single breath-hold Vd(m) calculation as good as multi breath-hold technique in Equilibrium Contrast CMR
por: Sado, Daniel, et al.
Publicado: (2012)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Diffuse interstitial fibrosis in well-controlled hypertension
por: Treibel, Thomas A, et al.
Publicado: (2013)

Interstitial expansion in health and disease - an equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Ascending aorta dilatation common feature which correlate with left ventricular hypertrophy in fabry disease
por: Bensalah, Mourad, et al.
Publicado: (2011)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease
por: Pastores, Gregory M
Publicado: (2007)

Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

The evolution and clinical importance of scar in hypertrophic cardiomyopathy - a 7 year CMR follow-up study
por: Quarta, Giovanni, et al.
Publicado: (2011)

Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation
por: Selthofer-Relatic, K.
Publicado: (2018)

Aortic arch stiffness in Fabry disease
por: Bensalah, Zoubir M, et al.
Publicado: (2013)

Role of cardiac imaging in Anderson-Fabry cardiomyopathy
por: Serra, Walter, et al.
Publicado: (2019)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review
por: Caputo, Fabio, et al.
Publicado: (2021)

Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
por: Esposito, Roberta, et al.
Publicado: (2021)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021)

Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
por: Ponsiglione, Andrea, et al.
Publicado: (2023)

Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
por: Averbuch, Tauben, et al.
Publicado: (2023)

A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy
por: Flett, Andrew, et al.
Publicado: (2013)

Angiokeratoma Corporis Diffusum: An Uncommon Case with Suspected Anderson Fabry Disease
por: Vadher, Priyanka, et al.
Publicado: (2020)

Anderson-fabry disease: role of traditional and new cardiac MRI techniques
por: Caredda, Gloria, et al.
Publicado: (2021)

ECG, LVH and T1 changes in Fabry disease - implications for screening and understanding of the disease model
por: Kozor, Rebecca, et al.
Publicado: (2016)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease
por: Halfmann, Moritz C., et al.
Publicado: (2022)

Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease
por: Kasuya, Shusuke, et al.
Publicado: (2016)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0qa0mnl1gapbbvdfglp0rv64lu